Artificial Intelligence | Machine Learning | Machine Perception Nostos Genomics | AI-Driven Deciphering of Genetic Diseases


Enterprise, Biotechnology, Diagnostics, Genetic Testing, Data Science Berlin, Germany

Nostos Genomics

Artificial Intelligence | Machine Learning | Machine Perception


Nostos Genomics | AI-Driven Deciphering of Genetic Diseases

Nostos Genomics

Biotechnology, Diagnostics, Genetic Testing, Data Science


Berlin, Germany

At Nostos Genomics, we partner with genetic testing labs to give more people with genetic diseases a fast and clear diagnosis. Over 300 million people live with a rare genetic disease and for most, the journey from the first symptoms to a diagnosis takes more than 5 years. Even after that, diagnoses are often incorrect, and many people end up not being diagnosed at all. Now, new technology is allowing millions to benefit from genetic testing for diagnosis, while at the same time targeted therapies for previously untreatable disorders are being developed. But the last step in genetic testing – interpreting mutations – remains laborious and costly. It can take a genetic testing lab weeks to interpret data from a single patient. Because of limited understanding of the consequences of mutations, the test results are often inconclusive and leave 70% of people undergoing a genetic test without diagnosis.

Our platform leverages a unique combination of machine learning and synthetic biology to characterize mutations at scale and automate the interpretation. By offering it to labs, we enable them to diagnose more people in a fraction of the time.

 

B2B

26 to 50

Funded

N/A

Scaling Up

2018

 
 

Managed Health Care
Healthcare
Biotechnology

N/A

Revenue Growth

 
 

Analytics
IT and Security
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception


N/A


Image

Image

Video

Video

Text

Text

Time Series

Time Series

 

   Software


N/A


N/A

 
 

4

1

$5.7M

Company was founded 2018 and it took almost 4 years (Feb 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

02/03/2022

Seed

$5.7M

42CAP, Frontline Ventures, Amino Capital, Entrepreneur First

Date : 02/03/2022

Round: Seed

$ Raised: $5.7M

Investors: 42CAP, Frontline Ventures, Amino Capital, Entrepreneur First

 

Investors

Interested in researching Nostos Genomics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Nostos Genomics

Request a Demo - Deal Souring Platform

 
David Gorgan


David Gorgan
Co-Founder & CEO

Rocío Acuña Hidalgo


Rocío Acuña Hidalgo
Co-founder & Chief Technology Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Nostos Genomics